메뉴 건너뛰기




Volumn 8, Issue 8, 2013, Pages

Plasma Asymmetric Dimethylarginine and Adverse Events in Patients with Atrial Fibrillation Referred for Coronary Angiogram

Author keywords

[No Author keywords available]

Indexed keywords

N(G),N(G) DIMETHYLARGININE;

EID: 84881329752     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071675     Document Type: Article
Times cited : (25)

References (35)
  • 1
    • 0035832261 scopus 로고    scopus 로고
    • Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study
    • Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, et al. (2001) Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285: 2370-2375.
    • (2001) JAMA , vol.285 , pp. 2370-2375
    • Go, A.S.1    Hylek, E.M.2    Phillips, K.A.3    Chang, Y.4    Henault, L.E.5
  • 2
    • 0028921708 scopus 로고
    • Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications
    • Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG, (1995) Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med 155: 469-473.
    • (1995) Arch Intern Med , vol.155 , pp. 469-473
    • Feinberg, W.M.1    Blackshear, J.L.2    Laupacis, A.3    Kronmal, R.4    Hart, R.G.5
  • 3
    • 79952770422 scopus 로고    scopus 로고
    • Lone atrial fibrillation: what is known and what is to come
    • Potpara TS, Lip GY, (2011) Lone atrial fibrillation: what is known and what is to come. Int J Clin Pract 65: 446-457.
    • (2011) Int J Clin Pract , vol.65 , pp. 446-457
    • Potpara, T.S.1    Lip, G.Y.2
  • 4
    • 0025779484 scopus 로고
    • Atrial fibrillation as an independent risk factor for stroke: the Framingham Study
    • Wolf PA, Abbott RD, Kannel WB, (1991) Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 22: 983-988.
    • (1991) Stroke , vol.22 , pp. 983-988
    • Wolf, P.A.1    Abbott, R.D.2    Kannel, W.B.3
  • 5
    • 33645501775 scopus 로고    scopus 로고
    • Asymmetric dimethylarginine (ADMA): a novel risk marker in cardiovascular medicine and beyond
    • Boger RH, (2006) Asymmetric dimethylarginine (ADMA): a novel risk marker in cardiovascular medicine and beyond. Ann Med 38: 126-136.
    • (2006) Ann Med , vol.38 , pp. 126-136
    • Boger, R.H.1
  • 6
    • 77951642455 scopus 로고    scopus 로고
    • The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular Disease
    • Sibal L, Agarwal SC, Home PD, Boger RH, (2010) The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular Disease. Curr Cardiol Rev 6: 82-90.
    • (2010) Curr Cardiol Rev , vol.6 , pp. 82-90
    • Sibal, L.1    Agarwal, S.C.2    Home, P.D.3    Boger, R.H.4
  • 7
    • 27744511357 scopus 로고    scopus 로고
    • Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study
    • Schnabel R, Blankenberg S, Lubos E, Lackner KJ, Rupprecht HJ, et al. (2005) Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study. Circ Res 97: e53-59.
    • (2005) Circ Res , vol.97
    • Schnabel, R.1    Blankenberg, S.2    Lubos, E.3    Lackner, K.J.4    Rupprecht, H.J.5
  • 8
    • 79960300381 scopus 로고    scopus 로고
    • Asymmetric dimethylarginine and clinical outcomes in chronic kidney disease
    • Lu TM, Chung MY, Lin CC, Hsu CP, Lin SJ, (2011) Asymmetric dimethylarginine and clinical outcomes in chronic kidney disease. Clin J Am Soc Nephrol 6: 1566-1572.
    • (2011) Clin J Am Soc Nephrol , vol.6 , pp. 1566-1572
    • Lu, T.M.1    Chung, M.Y.2    Lin, C.C.3    Hsu, C.P.4    Lin, S.J.5
  • 9
    • 74749108725 scopus 로고    scopus 로고
    • Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke
    • Schulze F, Carter AM, Schwedhelm E, Ajjan R, Maas R, et al. (2010) Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke. Atherosclerosis 208: 518-523.
    • (2010) Atherosclerosis , vol.208 , pp. 518-523
    • Schulze, F.1    Carter, A.M.2    Schwedhelm, E.3    Ajjan, R.4    Maas, R.5
  • 12
    • 70449705942 scopus 로고    scopus 로고
    • Effects of rosuvastatin on asymmetric dimethylarginine levels and early atrial fibrillation recurrence after electrical cardioversion
    • Xia W, Yin Z, Li J, Song Y, Qu X, (2009) Effects of rosuvastatin on asymmetric dimethylarginine levels and early atrial fibrillation recurrence after electrical cardioversion. Pacing Clin Electrophysiol 32: 1562-1566.
    • (2009) Pacing Clin Electrophysiol , vol.32 , pp. 1562-1566
    • Xia, W.1    Yin, Z.2    Li, J.3    Song, Y.4    Qu, X.5
  • 13
    • 84855658119 scopus 로고    scopus 로고
    • Asymmetric dimethylarginine concentration and recurrence of atrial tachyarrythmias after catheter ablation in patients with persistent atrial fibrillation
    • Yang L, Xiufen Q, Shuqin S, Yang Y, Ying S, et al. (2011) Asymmetric dimethylarginine concentration and recurrence of atrial tachyarrythmias after catheter ablation in patients with persistent atrial fibrillation. J Interv Card Electrophysiol 32: 147-154.
    • (2011) J Interv Card Electrophysiol , vol.32 , pp. 147-154
    • Yang, L.1    Xiufen, Q.2    Shuqin, S.3    Yang, Y.4    Ying, S.5
  • 14
    • 34249814933 scopus 로고    scopus 로고
    • HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation
    • Calkins H, Brugada J, Packer DL, Cappato R, Chen SA, et al. (2007) HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. Heart Rhythm 4: 816-861.
    • (2007) Heart Rhythm , vol.4 , pp. 816-861
    • Calkins, H.1    Brugada, J.2    Packer, D.L.3    Cappato, R.4    Chen, S.A.5
  • 15
    • 77957699729 scopus 로고    scopus 로고
    • Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)
    • Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, et al. (2010) Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 31: 2369-2429.
    • (2010) Eur Heart J , vol.31 , pp. 2369-2429
    • Camm, A.J.1    Kirchhof, P.2    Lip, G.Y.3    Schotten, U.4    Savelieva, I.5
  • 16
    • 76749163232 scopus 로고    scopus 로고
    • Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation
    • Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ, (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 137: 263-272.
    • (2010) Chest , vol.137 , pp. 263-272
    • Lip, G.Y.1    Nieuwlaat, R.2    Pisters, R.3    Lane, D.A.4    Crijns, H.J.5
  • 17
    • 0142209281 scopus 로고    scopus 로고
    • Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention
    • Lu TM, Ding YA, Lin SJ, Lee WS, Tai HC, (2003) Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention. Eur Heart J 24: 1912-1919.
    • (2003) Eur Heart J , vol.24 , pp. 1912-1919
    • Lu, T.M.1    Ding, Y.A.2    Lin, S.J.3    Lee, W.S.4    Tai, H.C.5
  • 18
    • 56049112978 scopus 로고    scopus 로고
    • Variance of DDAH/PRMT/ADMA pathway in atrial fibrillation dogs
    • Liu H, Qu X, Liang Z, Chen W, Xia W, et al. (2008) Variance of DDAH/PRMT/ADMA pathway in atrial fibrillation dogs. Biochem Biophys Res Commun 377: 884-888.
    • (2008) Biochem Biophys Res Commun , vol.377 , pp. 884-888
    • Liu, H.1    Qu, X.2    Liang, Z.3    Chen, W.4    Xia, W.5
  • 19
    • 31844444125 scopus 로고    scopus 로고
    • Lysophosphatidylcholine-induced elevation of asymmetric dimethylarginine level by the NADPH oxidase pathway in endothelial cells
    • Jia SJ, Jiang DJ, Hu CP, Zhang XH, Deng HW, et al. (2006) Lysophosphatidylcholine-induced elevation of asymmetric dimethylarginine level by the NADPH oxidase pathway in endothelial cells. Vascul Pharmacol 44: 143-148.
    • (2006) Vascul Pharmacol , vol.44 , pp. 143-148
    • Jia, S.J.1    Jiang, D.J.2    Hu, C.P.3    Zhang, X.H.4    Deng, H.W.5
  • 20
    • 83455230998 scopus 로고    scopus 로고
    • Pathogenic cycle between the endogenous nitric oxide synthase inhibitor asymmetrical dimethylarginine and the leukocyte-derived hemoprotein myeloperoxidase
    • von Leitner EC, Klinke A, Atzler D, Slocum JL, Lund N, et al. (2011) Pathogenic cycle between the endogenous nitric oxide synthase inhibitor asymmetrical dimethylarginine and the leukocyte-derived hemoprotein myeloperoxidase. Circulation 124: 2735-2745.
    • (2011) Circulation , vol.124 , pp. 2735-2745
    • von Leitner, E.C.1    Klinke, A.2    Atzler, D.3    Slocum, J.L.4    Lund, N.5
  • 21
    • 48249093448 scopus 로고    scopus 로고
    • Asymmetric dimethylarginine concentration and early recurrence of atrial fibrillation after electrical cardioversion
    • Xia W, Qu X, Yu Y, Zhang X, Feng W, et al. (2008) Asymmetric dimethylarginine concentration and early recurrence of atrial fibrillation after electrical cardioversion. Pacing Clin Electrophysiol 31: 1036-1040.
    • (2008) Pacing Clin Electrophysiol , vol.31 , pp. 1036-1040
    • Xia, W.1    Qu, X.2    Yu, Y.3    Zhang, X.4    Feng, W.5
  • 22
    • 79958796133 scopus 로고    scopus 로고
    • Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients
    • Roldan V, Marin F, Muina B, Torregrosa JM, Hernandez-Romero D, et al. (2011) Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients. J Am Coll Cardiol 57: 2496-2504.
    • (2011) J Am Coll Cardiol , vol.57 , pp. 2496-2504
    • Roldan, V.1    Marin, F.2    Muina, B.3    Torregrosa, J.M.4    Hernandez-Romero, D.5
  • 23
    • 84865258462 scopus 로고    scopus 로고
    • High sensitivity cardiac troponin T and interleukin-6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation
    • Roldan V, Marin F, Diaz J, Gallego P, Jover E, et al. (2012) High sensitivity cardiac troponin T and interleukin-6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation. J Thromb Haemost 10: 1500-1507.
    • (2012) J Thromb Haemost , vol.10 , pp. 1500-1507
    • Roldan, V.1    Marin, F.2    Diaz, J.3    Gallego, P.4    Jover, E.5
  • 24
    • 33644559016 scopus 로고    scopus 로고
    • Asymmetric dimethylarginine (ADMA) as a risk marker for stroke and TIA in a Swedish population
    • Wanby P, Teerlink T, Brudin L, Brattstrom L, Nilsson I, et al. (2006) Asymmetric dimethylarginine (ADMA) as a risk marker for stroke and TIA in a Swedish population. Atherosclerosis 185: 271-277.
    • (2006) Atherosclerosis , vol.185 , pp. 271-277
    • Wanby, P.1    Teerlink, T.2    Brudin, L.3    Brattstrom, L.4    Nilsson, I.5
  • 25
    • 0842347848 scopus 로고    scopus 로고
    • The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor
    • Boger RH, (2003) The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor. Cardiovasc Res 59: 824-833.
    • (2003) Cardiovasc Res , vol.59 , pp. 824-833
    • Boger, R.H.1
  • 26
    • 0028085059 scopus 로고
    • Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology
    • van der Wal AC, Becker AE, van der Loos CM, Das PK, (1994) Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 89: 36-44.
    • (1994) Circulation , vol.89 , pp. 36-44
    • van der Wal, A.C.1    Becker, A.E.2    van der Loos, C.M.3    Das, P.K.4
  • 27
    • 0041733065 scopus 로고    scopus 로고
    • Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase
    • Achan V, Broadhead M, Malaki M, Whitley G, Leiper J, et al. (2003) Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase. Arterioscler Thromb Vasc Biol 23: 1455-1459.
    • (2003) Arterioscler Thromb Vasc Biol , vol.23 , pp. 1455-1459
    • Achan, V.1    Broadhead, M.2    Malaki, M.3    Whitley, G.4    Leiper, J.5
  • 28
    • 33747186695 scopus 로고    scopus 로고
    • ADMA increases arterial stiffness and decreases cerebral blood flow in humans
    • Kielstein JT, Donnerstag F, Gasper S, Menne J, Kielstein A, et al. (2006) ADMA increases arterial stiffness and decreases cerebral blood flow in humans. Stroke 37: 2024-2029.
    • (2006) Stroke , vol.37 , pp. 2024-2029
    • Kielstein, J.T.1    Donnerstag, F.2    Gasper, S.3    Menne, J.4    Kielstein, A.5
  • 29
    • 77953682224 scopus 로고    scopus 로고
    • Influence of obesity on outcomes in atrial fibrillation: yet another obesity paradox
    • Badheka AO, Rathod A, Kizilbash MA, Garg N, Mohamad T, et al. (2010) Influence of obesity on outcomes in atrial fibrillation: yet another obesity paradox. Am J Med 123: 646-651.
    • (2010) Am J Med , vol.123 , pp. 646-651
    • Badheka, A.O.1    Rathod, A.2    Kizilbash, M.A.3    Garg, N.4    Mohamad, T.5
  • 30
    • 77955465471 scopus 로고    scopus 로고
    • Obesity and outcomes among patients with established atrial fibrillation
    • Ardestani A, Hoffman HJ, Cooper HA, (2010) Obesity and outcomes among patients with established atrial fibrillation. Am J Cardiol 106: 369-373.
    • (2010) Am J Cardiol , vol.106 , pp. 369-373
    • Ardestani, A.1    Hoffman, H.J.2    Cooper, H.A.3
  • 31
    • 77953851760 scopus 로고    scopus 로고
    • Underuse of oral anticoagulants in atrial fibrillation: a systematic review
    • Ogilvie IM, Newton N, Welner SA, Cowell W, Lip GY (2010) Underuse of oral anticoagulants in atrial fibrillation: a systematic review. Am J Med 123: 638-645 e634.
    • (2010) Am J Med , vol.123
    • Ogilvie, I.M.1    Newton, N.2    Welner, S.A.3    Cowell, W.4    Lip, G.Y.5
  • 32
    • 80053992926 scopus 로고    scopus 로고
    • Practice-level variation in warfarin use among outpatients with atrial fibrillation (from the NCDR PINNACLE program)
    • Chan PS, Maddox TM, Tang F, Spinler S, Spertus JA, (2011) Practice-level variation in warfarin use among outpatients with atrial fibrillation (from the NCDR PINNACLE program). Am J Cardiol 108: 1136-1140.
    • (2011) Am J Cardiol , vol.108 , pp. 1136-1140
    • Chan, P.S.1    Maddox, T.M.2    Tang, F.3    Spinler, S.4    Spertus, J.A.5
  • 33
    • 78650951581 scopus 로고    scopus 로고
    • A comparison of risk stratification schemes for stroke in 79,884 atrial fibrillation patients in general practice
    • Van Staa TP, Setakis E, Di Tanna GL, Lane DA, Lip GY, (2011) A comparison of risk stratification schemes for stroke in 79,884 atrial fibrillation patients in general practice. J Thromb Haemost 9: 39-48.
    • (2011) J Thromb Haemost , vol.9 , pp. 39-48
    • Van Staa, T.P.1    Setakis, E.2    Di Tanna, G.L.3    Lane, D.A.4    Lip, G.Y.5
  • 34
    • 84861725443 scopus 로고    scopus 로고
    • Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study
    • Friberg L, Rosenqvist M, Lip GY, (2012) Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study. Eur Heart J 33: 1500-1510.
    • (2012) Eur Heart J , vol.33 , pp. 1500-1510
    • Friberg, L.1    Rosenqvist, M.2    Lip, G.Y.3
  • 35
    • 84868523625 scopus 로고    scopus 로고
    • 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association
    • Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, et al. (2012) 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 33: 2719-2747.
    • (2012) Eur Heart J , vol.33 , pp. 2719-2747
    • Camm, A.J.1    Lip, G.Y.2    De Caterina, R.3    Savelieva, I.4    Atar, D.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.